Early engagement with the Alzheimer’s disease (AD) community to gain insights into designing the SKYLINE trial in cognitively unimpaired people at risk for progression due to AD

A positive feedback loop between chronic lysosomal dysfunction and circRNAs in Alzheimer’s disease mouse models